Trial Profile
A phase I study to evaluate the tolerability, pharmacokinetics and preliminary pharmacodynamics of Lyophilized recombinant human keratinocyte growth factor in healthy subjects
Status:
Recruiting
Phase of Trial:
Phase I
Latest Information Update: 20 Jun 2016
Price :
$35
*
At a glance
- Drugs Palifermin (Primary)
- Indications Stomatitis
- Focus Adverse reactions
- Sponsors Genemen Biotech
- 07 Jan 2014 New trial record